• Pre Clinical And Clinical Research

WCCT GLOBAL (an Altasciences Company) Clinic Expansion

Laval, Quebec, March 23, 2021 – WCCT Global, an Altasciences company, announced the expansion of their clinical pharmacology unit and laboratory earlier this year. Today, Altasciences confirms the unit dosed its first study participants.

Medannex unveils the multiple anti-cancer effects of MDX-124 at AACR Annual Meeting 2021

Medannex Ltd (Edinburgh) today announced the presentation of new data at the annual meeting of the American Association for Cancer Research (AACR), highlighting the multi-faceted anti-cancer activity of MDX-124 - the company’s proprietary therapeutic antibody.

FairJourney Biologics enters next-generation antibody discovery collaboration with argenx

• Collaboration to leverage IONTAS proprietary mammalian display technology • Differentiated antibody candidates that emerge from collaboration may advance into argenx immunology pipeline

Guest Blog|Could our immune system be why COVID-19 is so deadly?

Respiratory viruses such as SARS-CoV-2 often catalyse an overactive immune response that leads to a life-threatening cycle, known as a cytokine storm. Analysing cytokine responses from patients has unearthed glaringly important differences in how SARS-CoV-2 affects cytokines compared to other common respiratory viruses.

Medannex sweeps the board at Scotland’s Life Sciences Annual Awards

Medannex Ltd (Edinburgh) this week received multiple awards in recognition of notable successes in several key areas. The late-stage biopharmaceutical company, developing novel treatments for cancers and autoimmune diseases, was declared the winner in all three categories in which it was nominated at Scotland’s Life Sciences Annual Awards.

IONTAS identifies novel SARS-CoV-2 neutralising antibodies

• Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant • IONTAS now seeking development partners

Altasciences Doubles Square Footage of Their CDMO Facility

Altasciences Doubles Square Footage of Their CDMO Facility


Laval, Quebec, February 19, 2020 – Altasciences announced today that they have acquired WCCT Global, Inc., an early stage clinical research organization, or CRO, located in Southern California on the U.S.A.’s West Coast. This acquisition will complement Altasciences’ current clinical operations in Montreal, Canada, and Kansas City, U.S.A., while being in close proximity to their Washington State preclinical facility.

WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers

WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the acquisition of OXGENE, a pioneering United Kingdom-based contract research and development organization that designs and develops scalable gene therapy technologies

Polish expansion for Discovery Park-based science team boosts European connectivity for Kent and UK

A team of Discovery Park scientists researching human neurological and psychiatric health conditions is expanding research opportunities for its Kent-based team in mainland Europe, by opening an additional laboratory in Poland.